Back

Prevention of heart failure readmission in patients with left ventricular assist device (LVAD): role of pump optimization and medical therapy

14 May 2024 (09:12 - 09:21)
Organised by: Logo
Congress Presentation Part of: Acute, advanced and worsening heart failure: prognostic aspects Ventricular Assist Devices HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Chiara Marcelli

IRCCS Sant'Orsola Polyclinic, Bologna (Italy)

6 More presentations in this session

Presentation thumbnail
Serum chloride and the response to acetazolamide in patients with acute heart failure and volume overload: a post-hoc analysis from the ADVOR trial
Doctor J. Van den Eynde (Leuven, BE)
Abstract Slides Video
Presentation thumbnail
Length of hospital stay, re-hospitalization rates and comorbidities in patients with worsening heart failure. Data from 3 large cohort studies in the US, Germany and Japan.
Doctor A. Michel (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Impact of defibrillators on mortality in patients with quadruple guideline-directed medical therapy: a propensity score-matched study
Assistant Professor A. Sahin (Canakkale, TR)
Abstract Slides Video
Presentation thumbnail
ICCU-HF score for predicting 1-year heart failure outcomes in patients hospitalised in intensive cardiac care units
Doctor A. Tinggaard (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: insights from the HELP-HF registry
Doctor A. Villaschi (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Acute, advanced and worsening heart failure: prognostic aspects
Video

The Event

Event poster

Heart Failure 2024

14 May 2024 09:12 CET
You may be interested in
thumbnail
Congress Session
Advanced therapies in heart failure
thumbnail
Congress Presentation
Can heart failure guideline-directed medical therapy improve left ventricular assist device outcomes?
thumbnail
Congress Session
Acute, advanced and worsening heart failure: prognostic aspects

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources